Skip to main content
. 2020 Sep 8;79:111017. doi: 10.1016/j.nut.2020.111017

Table 2.

Univariate and multivariate analyses of OR in developing primary outcome requiring oxygen therapy for clinical variables and DMB therapy

Unadjusted univariate analysis
Adjusted multivariate analysis
Variable OR for requiring oxygen therapy 95% CI P-value Variables OR for requiring oxygen therapy 95% CI P-value
DMB 0.134 0.031–0.586 0.008 DMB 0.195 0.041–0.926 0.040
Age, y 1.131 1.006–1.271 0.039
Age, y 1.150 1.035–1.278 0.009
DMB 0.182 0.038–0.859 0.031
Hypertension 6.250 1.575–24.798 0.009 Hypertension 4.528 1.041–19.694 0.044
Male 2.800 0.765–10.246 0.120
Comorbidities 3.173 0.811–12.416 0.097
DM * 0.999
Hyperlipidemia 3.429 0.972–12.095 0.055
CVD 8.214 0.868–77.739 0.066
Asthma/COPD 1.294 0.165–10.150 0.806
Stroke * 0.999

COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; DM, diabetes mellitus; DMB, vitamin D, magnesium, vitamin B12; OR, odds ratio.

P-values < 0.05 are highlighted in bold.

Not estimable.